Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations —After FDA rejection, Gilead nears full EU nod for hep D drug — Judge orders J&J, talc opponents to engage in settlement talks -- See more on our front page news http://bit.ly/w28kSd #earnings #biogen #novartis #sanofi #gileadsciences #hepatitisd #legal #bankruptcy #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #biogen #novartis #Sanofi #gileadsciences #hepatitisd #legal #bankruptcy #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Revenues down for Moderna, up for Regeneron in Q1 —Roche opens new institute to advance research in human model systems — ImmunoGen reports positive top-line data from ovarian cancer therapy trial -- See more on our front page news http://bit.ly/w28kSd #earnings #moderna #regeneron #roche #researchanddevelopment #clinicaltrials #ovariancancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #moderna #regeneron #roche #researchanddevelopment #clinicaltrials #ovariancancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Lilly drug slows Alzheimer’s decline in large study —FDA encourages decentralized trials with new guidance — Masimo suit against Apple over smartwatch trade secrets ends in mistrial -- See more on our front page news http://bit.ly/w28kSd #alzheimers #fda #elililly #clinicaltrials #legal #apple #masimo #tradesecrets #smartwatch #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#alzheimers #FdA #elililly #clinicaltrials #legal #apple #masimo #tradesecrets #smartwatch #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Pfizer reports strong Q1 earnings, including $18.3B in revenues —Analyst ‘blown away’ by robot-fueled growth of Stryker’s hip and knee sales — One-third of US nurses plan to quit profession -- See more on our front page news http://bit.ly/w28kSd #pfizer #earnings #covid19 #vaccines #medtech #nurses #stryker #roboticsurgery #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#pfizer #earnings #covid19 #vaccines #medtech #nurses #stryker #roboticsurgery #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Astellas to acquire eye drug developer Iveric Bio for $5.9B —With negative FDA panel vote, AstraZeneca's Lynparza looks set for narrow nod in prostate cancer—Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify -- See more on our front page news http://bit.ly/w28kSd #astellas #mergersandacquisitions #eyehealth #fda #prostatecancer #astrazeneca #abilify #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#astellas #mergersandacquisitions #eyehealth #FdA #ProstateCancer #astrazeneca #abilify #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too —FDA sent letter to HCPs warning of cybersecurity risk in Illumina sequencing software—GSK's RSV vaccine first to get EU regulator's nod -- See more on our front page news http://bit.ly/w28kSd #fda #amgen #lupus #elililly #hcps #cybersecurity #illumina #rsv #gsk #europe #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #amgen #lupus #elililly #HCPs #cybersecurity #illumina #RSV #gsk #europe #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA approves first oral microbiome therapy Vowst —EU publishes proposed drug laws overhaul, setting up tussle with industry—Lilly drug Mounjaro succeeds in second weight loss study -- See more on our front page news http://bit.ly/w28kSd #fda #microbiome #eu #europe #pharmaindustry #elililly #obesity #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #microbiome #eu #europe #pharmaindustry #elililly #obesity #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
US Senate kicks off fresh round of drug pricing control legislation —FDA approves Biogen and Ionis’ Tofersen for rare genetic form of ALS—Novartis culls 10% of pipeline, doubles down on five core therapeutic areas-- See more on our front page news http://bit.ly/w28kSd #earnings #biogen #novartis #senate #legislation #drugpricing #als #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #biogen #novartis #senate #Legislation #drugpricing #ALS #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Busy with 3 program launches this year, Biogen trims pipeline —Novartis, helped by cost cuts, raises full-year outlook—Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO-- See more on our front page news http://bit.ly/w28kSd #earnings #biogen #novartis #jnj #consumerhealth #ipos #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #biogen #novartis #jnj #consumerhealth #ipos #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Big Pharma’s R&D spending flatlined in 2022: What it means for the industry —Bluebird Bio submits BLA for sickle cell disease gene therapy—Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy-- See more on our front page news http://bit.ly/w28kSd #bigpharma #researchanddevelopment #bluebirdbio #sicklecelldisease #genetherapy #obesity #elililly #novonordisk #wegovy #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#bigpharma #researchanddevelopment #bluebirdbio #Sicklecelldisease #genetherapy #obesity #elililly #novonordisk #wegovy #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs —Boehringer taps RetinAI for AI boost to eye disease R&D—Big pharma holds steady on research spending-- See more on our front page news http://bit.ly/w28kSd #researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
BMS signs ADC development deal with Munich-based biotech worth more than $1B —BeiGene's gastric cancer drug succeeds in late-stage trial— FDA green lights Roche's Polivy in first-line DLBCL-- See more on our front page news http://bit.ly/w28kSd #bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Abbott sales 18% fall due to anticipation of COVID testing sales declines —AstraZeneca confident new COVID antibody protects against known variants— J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma -- See more on our front page news http://bit.ly/w28kSd #abbottlabs #earnings #covid #covid19 #antibodies #astrazeneca #jnj #aacr #multiplemyeloma #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#abbottlabs #earnings #covid #covid19 #antibodies #astrazeneca #jnj #aacr #multiplemyeloma #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
GSK coughs up $2B for Bellus Health —J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit— Supreme Court slaps down separate bids from Novartis, Sanofi -- See more on our front page news http://bit.ly/w28kSd #gsk #chroniccough #jnj #earnings #supremecourt #novartis #sanofi #mergersandacquisitions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#gsk #chroniccough #jnj #earnings #SupremeCourt #novartis #Sanofi #mergersandacquisitions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
J&J opens the valve on $50M MS partnership with Pipeline — The end of an era: Regeneron chairman Roy Vagelos to retire after 29-year run— Merck to buy inflammatory disease drugmaker Prometheus for $10.8B -- See more on our front page news http://bit.ly/w28kSd #JNJ #ms #multiplesclerosis #chairman #regeneron #merck #inflammatorydisease #mergersandacquisitions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#jnj #ms #multiplesclerosis #chairman #regeneron #merck #inflammatorydisease #mergersandacquisitions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA rejects Teva’s high-potency biosimilar of Humira again — After a record run, fewer biotechs are going public— Sarepta shares drop as report says FDA almost rejected under-review gene therapy -- See more on our front page news http://bit.ly/w28kSd #tevapharma #fda #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#tevapharma #FdA #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Biotechs see 'staggering' 87% rise in layoffs during Q1 — Novo’s latest deal targets cell therapy for diabetes, obesity— Appeals court rules abortion drug can stay on market — but limits access -- See more on our front page news http://bit.ly/w28kSd #layoffs #jobcuts #novonordisk #diabetes #obesity #abortionpill #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#layoffs #jobcuts #novonordisk #diabetes #obesity #abortionpill #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Moderna announces new vaccine candidates against Lyme disease and norovirus — Merck KGaA's multiple sclerosis drug hit with partial FDA hold — Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch -- See more on our front page news http://bit.ly/w28kSd #moderna #vaccines #mrna #lymedisease #norovirus #ms #multiplesclerosis #merckkgaa #fda #sanofi #rsv #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#moderna #vaccines #mrna #lymedisease #norovirus #ms #multiplesclerosis #merckkgaa #FdA #Sanofi #RSV #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned? — Biopharma rallies behind FDA after Texas abortion pill ruling — Moderna sees up to $15 bln in respiratory vaccine sales in 2027 -- See more on our front page news http://bit.ly/w28kSd #mergersandacquisitions #ftc #antitrust #sanofi #pfizer #fda #abortionpill #moderna #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#mergersandacquisitions #FTC #antitrust #Sanofi #pfizer #FdA #abortionpill #moderna #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
In another round of cuts, Biogen lays off unspecified number of employees — Big Pharma-partnered Evotec on high alert after cyber attack takes systems offline — Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus -- See more on our front page news http://bit.ly/w28kSd #biogen #layoffs #cybersecurity #cyberattack #clovisoncology #bankruptcy #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#biogen #layoffs #cybersecurity #CyberAttack #clovisoncology #bankruptcy #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma